NO995404L - Forbindelser - Google Patents

Forbindelser

Info

Publication number
NO995404L
NO995404L NO995404A NO995404A NO995404L NO 995404 L NO995404 L NO 995404L NO 995404 A NO995404 A NO 995404A NO 995404 A NO995404 A NO 995404A NO 995404 L NO995404 L NO 995404L
Authority
NO
Norway
Prior art keywords
compounds
thienyl
racemates
therapy
alkyl
Prior art date
Application number
NO995404A
Other languages
English (en)
Norwegian (no)
Other versions
NO995404D0 (no
Inventor
James Macdonald
James Matz
William Shakespeare
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO995404D0 publication Critical patent/NO995404D0/no
Publication of NO995404L publication Critical patent/NO995404L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO995404A 1997-05-05 1999-11-04 Forbindelser NO995404L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701682A SE9701682D0 (sv) 1997-05-05 1997-05-05 Compounds
PCT/SE1998/000792 WO1998050380A1 (en) 1997-05-05 1998-04-28 Compounds

Publications (2)

Publication Number Publication Date
NO995404D0 NO995404D0 (no) 1999-11-04
NO995404L true NO995404L (no) 2000-01-05

Family

ID=20406836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995404A NO995404L (no) 1997-05-05 1999-11-04 Forbindelser

Country Status (28)

Country Link
US (1) US6166030A (ja)
EP (1) EP0983266B1 (ja)
JP (1) JP2001523263A (ja)
KR (1) KR20010012227A (ja)
CN (1) CN1255130A (ja)
AR (1) AR012602A1 (ja)
AT (1) ATE210661T1 (ja)
AU (1) AU734394B2 (ja)
BR (1) BR9808725A (ja)
CA (1) CA2287999A1 (ja)
DE (1) DE69802923T2 (ja)
DK (1) DK0983266T3 (ja)
EE (1) EE9900475A (ja)
ES (1) ES2168757T3 (ja)
HU (1) HUP0003766A3 (ja)
ID (1) ID23156A (ja)
IL (1) IL132677A0 (ja)
IS (1) IS5237A (ja)
MX (1) MXPA99009874A (ja)
NO (1) NO995404L (ja)
NZ (1) NZ500676A (ja)
PL (1) PL336854A1 (ja)
PT (1) PT983266E (ja)
SE (1) SE9701682D0 (ja)
SK (1) SK140699A3 (ja)
TR (1) TR199902719T2 (ja)
WO (1) WO1998050380A1 (ja)
ZA (1) ZA983740B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566081B1 (en) 1999-10-06 2003-05-20 The Brigham And Women's Hospital, Inc. Methods of identifying a compound which modulates the non-transcriptional non-map-kinase induced effects of steroid hormones
US6683108B1 (en) * 2000-03-30 2004-01-27 Curis, Inc. Agonists of hedgehog signaling pathways and uses related thereto
US8852937B2 (en) * 2000-03-30 2014-10-07 Curis, Inc. Small organic molecule regulators of cell proliferation
US7115653B2 (en) * 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
JP5833804B2 (ja) 2005-04-13 2015-12-16 ニューラクソン，インコーポレーテッド Ｎｏｓ阻害活性を有する置換インドール化合物
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
KR20100103799A (ko) 2007-11-16 2010-09-28 네우렉슨 인코포레이티드 내장통을 치료하기 위한 인돌 화합물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169280A1 (en) * 1993-08-12 1995-02-23 Robert James Gentile Amidine derivatives with nitric oxide synthetase activities
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
CA2188680A1 (en) * 1994-05-07 1996-01-25 James Edwin Macdonald Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
KR970706272A (ko) * 1995-08-10 1997-11-03 클래스 빌헬름슨 치료에 유용한 바이시클릭 아미딘 유도체(Bicyclic Amidine Derivatives Useful in Therapy)

Also Published As

Publication number Publication date
WO1998050380A1 (en) 1998-11-12
PT983266E (pt) 2002-05-31
AU7460098A (en) 1998-11-27
EP0983266B1 (en) 2001-12-12
SE9701682D0 (sv) 1997-05-05
AR012602A1 (es) 2000-11-08
ZA983740B (en) 1999-02-19
EE9900475A (et) 2000-06-15
MXPA99009874A (es) 2004-09-30
NO995404D0 (no) 1999-11-04
AU734394B2 (en) 2001-06-14
SK140699A3 (en) 2000-06-12
ATE210661T1 (de) 2001-12-15
NZ500676A (en) 2001-05-25
IL132677A0 (en) 2001-03-19
BR9808725A (pt) 2000-07-11
DK0983266T3 (da) 2002-03-11
ID23156A (id) 2000-03-23
EP0983266A1 (en) 2000-03-08
CA2287999A1 (en) 1998-11-12
CN1255130A (zh) 2000-05-31
US6166030A (en) 2000-12-26
HUP0003766A2 (en) 2001-03-28
DE69802923T2 (de) 2002-07-04
ES2168757T3 (es) 2002-06-16
TR199902719T2 (xx) 2000-02-21
PL336854A1 (en) 2000-07-17
JP2001523263A (ja) 2001-11-20
DE69802923D1 (de) 2002-01-24
HUP0003766A3 (en) 2001-09-28
KR20010012227A (ko) 2001-02-15
IS5237A (is) 1999-11-01

Similar Documents

Publication Publication Date Title
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
PL328270A1 (en) Derivatives of sulphonated amino acids and inhibitors of metaloproteinase containing such derivatives
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
NO972910L (no) Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
NO934196L (no) N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for deres fremstilling
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
NO995404L (no) Forbindelser
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NO995403L (no) Amidinderivater som inhibitorer av nitrogenoksydsyntase
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
NO982072L (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO982863L (no) Nye forbindelser med analgetisk effekt
CA2211681A1 (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
NO20013601L (no) Nye morfolinobenzamidsalter
SE9904676D0 (sv) Novel compounds
DK17581A (da) 2,3-dihydro-imidazo (1,2-b) pyridaziner fremgangsmaade til deres fremstilling samt deres anvendelse
SE9901901D0 (sv) Compounds
NO996544L (no) Forbindelser
NO963374L (no) Substituerte 4H-pyraner
NO995007L (no) Forbindelser
NO20021310L (no) Aminderivater
NO992552L (no) Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application